The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

Lakeman IMM, van den Broek AJ, Vos JAM, Barnes DR, Adlard J, Andrulis IL, Arason A, Arnold N, Arun BK, Balmaña J, Barrowdale D, Benitez J, Borg A, Caldés T, Caligo MA, Chung WK, Claes KBM, GEMO Study Collaborators, EMBRACE Collaborators, Collée JM, Couch FJ, Daly MB, Dennis J, Dhawan M, Domchek SM, Eeles R, Engel C, Evans DG, Feliubadaló L, Foretova L, Friedman E, Frost D, Ganz PA, Garber J, Gayther SA, Gerdes AM, Godwin AK, Goldgar DE, Hahnen E, Hake CR, Hamann U, Hogervorst FBL, Hooning MJ, Hopper JL, Hulick PJ, Imyanitov EN, OCGN Investigators, HEBON Investigators, KconFab Investigators, Isaacs C, Izatt L, Jakubowska A, James PA, Janavicius R, Jensen UB, Jiao Y, John EM, Joseph V, Karlan BY, Kets CM, Konstantopoulou I, Kwong A, Legrand C, Leslie G, Lesueur F, Loud JT, Lubiński J, Manoukian S, McGuffog L, Miller A, Gomes DM, Montagna M, Mouret-Fourme E, Nathanson KL, Neuhausen SL, Nevanlinna H, Yie JNY, Olah E, Olopade OI, Park SK, Parsons MT, Peterlongo P, Piedmonte M, Radice P, Rantala J, Rennert G, Risch HA, Schmutzler RK, Sharma P, Simard J, Singer CF, Stadler Z, Stoppa-Lyonnet D, Sutter C, Tan YY, Teixeira MR, Teo SH, Teulé A, Thomassen M, Thull DL, Tischkowitz M, Toland AE, Tung N, van Rensburg EJ, Vega A, Wappenschmidt B, Devilee P, van Asperen CJ, Bernstein JL, Offit K, Easton DF, Rookus MA, Chenevix-Trench G, Antoniou AC, Robson M, Schmidt MK.

Open source

DOI: 10.1038/s41436-021-01198-7
Published: 2021-06-10
Container: Genet Med
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41436-021-01198-7,
  title = {The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.},
  author = {Lakeman IMM and  van den Broek AJ and  Vos JAM and  Barnes DR and  Adlard J and  Andrulis IL and  Arason A and  Arnold N and  Arun BK and  Balmaña J and  Barrowdale D and  Benitez J and  Borg A and  Caldés T and  Caligo MA and  Chung WK and  Claes KBM and  GEMO Study Collaborators and  EMBRACE Collaborators and  Collée JM and  Couch FJ and  Daly MB and  Dennis J and  Dhawan M and  Domchek SM and  Eeles R and  Engel C and  Evans DG and  Feliubadaló L and  Foretova L and  Friedman E and  Frost D and  Ganz PA and  Garber J and  Gayther SA and  Gerdes AM and  Godwin AK and  Goldgar DE and  Hahnen E and  Hake CR and  Hamann U and  Hogervorst FBL and  Hooning MJ and  Hopper JL and  Hulick PJ and  Imyanitov EN and  OCGN Investigators and  HEBON Investigators and  KconFab Investigators and  Isaacs C and  Izatt L and  Jakubowska A and  James PA and  Janavicius R and  Jensen UB and  Jiao Y and  John EM and  Joseph V and  Karlan BY and  Kets CM and  Konstantopoulou I and  Kwong A and  Legrand C and  Leslie G and  Lesueur F and  Loud JT and  Lubiński J and  Manoukian S and  McGuffog L and  Miller A and  Gomes DM and  Montagna M and  Mouret-Fourme E and  Nathanson KL and  Neuhausen SL and  Nevanlinna H and  Yie JNY and  Olah E and  Olopade OI and  Park SK and  Parsons MT and  Peterlongo P and  Piedmonte M and  Radice P and  Rantala J and  Rennert G and  Risch HA and  Schmutzler RK and  Sharma P and  Simard J and  Singer CF and  Stadler Z and  Stoppa-Lyonnet D and  Sutter C and  Tan YY and  Teixeira MR and  Teo SH and  Teulé A and  Thomassen M and  Thull DL and  Tischkowitz M and  Toland AE and  Tung N and  van Rensburg EJ and  Vega A and  Wappenschmidt B and  Devilee P and  van Asperen CJ and  Bernstein JL and  Offit K and  Easton DF and  Rookus MA and  Chenevix-Trench G and  Antoniou AC and  Robson M and  Schmidt MK.},
  year = {2021},
  journal = {Genet Med},
  doi = {10.1038/s41436-021-01198-7},
  url = {https://doi.org/10.1038/s41436-021-01198-7}
}

RIS

TY  - JOUR
TI  - The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
AU  - Lakeman IMM
AU  -  van den Broek AJ
AU  -  Vos JAM
AU  -  Barnes DR
AU  -  Adlard J
AU  -  Andrulis IL
AU  -  Arason A
AU  -  Arnold N
AU  -  Arun BK
AU  -  Balmaña J
AU  -  Barrowdale D
AU  -  Benitez J
AU  -  Borg A
AU  -  Caldés T
AU  -  Caligo MA
AU  -  Chung WK
AU  -  Claes KBM
AU  -  GEMO Study Collaborators
AU  -  EMBRACE Collaborators
AU  -  Collée JM
AU  -  Couch FJ
AU  -  Daly MB
AU  -  Dennis J
AU  -  Dhawan M
AU  -  Domchek SM
AU  -  Eeles R
AU  -  Engel C
AU  -  Evans DG
AU  -  Feliubadaló L
AU  -  Foretova L
AU  -  Friedman E
AU  -  Frost D
AU  -  Ganz PA
AU  -  Garber J
AU  -  Gayther SA
AU  -  Gerdes AM
AU  -  Godwin AK
AU  -  Goldgar DE
AU  -  Hahnen E
AU  -  Hake CR
AU  -  Hamann U
AU  -  Hogervorst FBL
AU  -  Hooning MJ
AU  -  Hopper JL
AU  -  Hulick PJ
AU  -  Imyanitov EN
AU  -  OCGN Investigators
AU  -  HEBON Investigators
AU  -  KconFab Investigators
AU  -  Isaacs C
AU  -  Izatt L
AU  -  Jakubowska A
AU  -  James PA
AU  -  Janavicius R
AU  -  Jensen UB
AU  -  Jiao Y
AU  -  John EM
AU  -  Joseph V
AU  -  Karlan BY
AU  -  Kets CM
AU  -  Konstantopoulou I
AU  -  Kwong A
AU  -  Legrand C
AU  -  Leslie G
AU  -  Lesueur F
AU  -  Loud JT
AU  -  Lubiński J
AU  -  Manoukian S
AU  -  McGuffog L
AU  -  Miller A
AU  -  Gomes DM
AU  -  Montagna M
AU  -  Mouret-Fourme E
AU  -  Nathanson KL
AU  -  Neuhausen SL
AU  -  Nevanlinna H
AU  -  Yie JNY
AU  -  Olah E
AU  -  Olopade OI
AU  -  Park SK
AU  -  Parsons MT
AU  -  Peterlongo P
AU  -  Piedmonte M
AU  -  Radice P
AU  -  Rantala J
AU  -  Rennert G
AU  -  Risch HA
AU  -  Schmutzler RK
AU  -  Sharma P
AU  -  Simard J
AU  -  Singer CF
AU  -  Stadler Z
AU  -  Stoppa-Lyonnet D
AU  -  Sutter C
AU  -  Tan YY
AU  -  Teixeira MR
AU  -  Teo SH
AU  -  Teulé A
AU  -  Thomassen M
AU  -  Thull DL
AU  -  Tischkowitz M
AU  -  Toland AE
AU  -  Tung N
AU  -  van Rensburg EJ
AU  -  Vega A
AU  -  Wappenschmidt B
AU  -  Devilee P
AU  -  van Asperen CJ
AU  -  Bernstein JL
AU  -  Offit K
AU  -  Easton DF
AU  -  Rookus MA
AU  -  Chenevix-Trench G
AU  -  Antoniou AC
AU  -  Robson M
AU  -  Schmidt MK.
PY  - 2021
JO  - Genet Med
DO  - 10.1038/s41436-021-01198-7
UR  - https://doi.org/10.1038/s41436-021-01198-7
ER  -

APA

IMM, L., AJ, V. D. B., JAM, V., DR, B., J, A., IL, A., A, A., N, A., BK, A., J, B., D, B., J, B., A, B., T, C., MA, C., WK, C., KBM, C., Collaborators, G. S., Collaborators, E., JM, C., FJ, C., MB, D., J, D., M, D., SM, D., R, E., C, E., DG, E., L, F., L, F., E, F., D, F., PA, G., J, G., SA, G., AM, G., AK, G., DE, G., E, H., CR, H., U, H., FBL, H., MJ, H., JL, H., PJ, H., EN, I., Investigators, O., Investigators, H., Investigators, K., C, I., L, I., A, J., PA, J., R, J., UB, J., Y, J., EM, J., V, J., BY, K., CM, K., I, K., A, K., C, L., G, L., F, L., JT, L., J, L., S, M., L, M., A, M., DM, G., M, M., E, M., KL, N., SL, N., H, N., JNY, Y., E, O., OI, O., SK, P., MT, P., P, P., M, P., P, R., J, R., G, R., HA, R., RK, S., P, S., J, S., CF, S., Z, S., D, S., C, S., YY, T., MR, T., SH, T., A, T., M, T., DL, T., M, T., AE, T., N, T., EJ, V. R., A, V., B, W., P, D., CJ, V. A., JL, B., K, O., DF, E., MA, R., G, C., AC, A., M, R., & MK., S. (2021). The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.. Genet Med. https://doi.org/10.1038/s41436-021-01198-7

Source records

europe-pmc · retrieved 2026-09-26T12:57:58.382Z